Skip to main content

Table 3 Total and separate cell percentage and counts in peripherial blood and BAL fluid

From: Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease

Variable

Lung cancer group

Control group

Without COPD

With COPD

COPD

Healthy individuals

Peripheral blood cells, mean ± SEM:

    

Leukocytes, x109l

8.57 ± 0.25*§

8.71 ± 0.48*§

5.81 ± 0.13*

5.35 ± 0.17

Neutrophils, %

65.34 ± 0.85*§

67.45 ± 1.43*§

61.77 ± 1.18*

56.92 ± 1.65

Neutrophils, x109l

5.72 ± 0.22*§

5.96 ± 0.39*§

4.35 ± 0.22*

3.70 ± 0.25

Lymphocytes, %

23.01 ± 0.79*§

21.11 ± 1.21*§

25.93 ± 0.99*

31.64 ± 1.45

Lymphocytes, x109l

1.88 ± 0.06

1.84 ± 0.10

1.78 ± 0.09

1.99 ± 0.09

Monocytes, %

8.60 ± 0.30*§

8.10 ± 0.49*§

6.82 ± 0.29

6.26 ± 0.42

Monocytes, x109l

0.87 ± 0.09*§

0.88 ± 0.17*§

0.46 ± 0.03

0.40 ± 0.03

Neutrophil/lymphocyte ratio, median (range)

2.92(0.93–13.42)*§

3.08(1.18–8.84)* §

2.35(1.13–4.25)§

1.86(1.16–3.21)

BAL fluid cells, mean ± SEM:

    

Neutrophils, %

8.01 ± 1.37*§

7.94 ± 0.83*§

14.10 ± 2.96*

1.29 ± 0.21

Neutrophils, x106/ml

0.39 ± 0.12*§

0.41 ± 0.15*§

0.54 ± 0.22*

0.08 ± 0.05

Macrophages, %

73.59 ± 1.51§

72.89 ± 1.71§

65.50 ± 3.19*

74.40 ± 1.77

Macrophages, x106/ml

3.24 ± 0.20§

3.15 ± 0.30§

2.95 ± 0.65*

3.21 ± 0.51

Lymphocytes, %

18.21 ± 1.02

18.81 ± 1.48

19.99 ± 1.80

21.97 ± 1.62

Lymphocytes, x106/ml

0.87 ± 0.34

1.03 ± 0.37

1.11 ± 0.53

0.63 ± 0.26

Eosinophils, %

0.29 ± 0.04

0.36 ± 0.06

0.41 ± 0.15

0.34 ± 0.11

Eosinophils, x106/ml

0.02 ± 0.01

0.01 ± 0.01

0.03 ± 0.01

0.02 ± 0.01

  1. Data are expressed as mean ± SEM. *P < 0.05 when compared with healthy individuals; §P < 0.05 when compared to COPD group.